Shares of Celgene Corporation (NASDAQ:CELG) and Biogen, Inc. (NASDAQ:BIIB), two top holdings of the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the total
...
Shares of Gilead Sciences
(NASDAQ:GILD) have underperformed the iShares Nasdaq Biotechnology ETF
(NASDAQ:IBB), which tracks the total return performance ...
Speculation of a potential Regeneron Pharmaceuticals
(NASDAQ:REGN) takeover deal by big pharma companies has resurfaced once again as companies such as Pfizer
...
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the total return performance of the Nasdaq Biotechnology Index (NBI), is up 15.2% since it hit a
...
Shares of Biogen Inc. (NASDAQ:BIIB) have gained about 3.8% since December 19, when the company announced the appointment of Chief Commercial Officer and Executive
...
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the total return performance of the Nasdaq Biotechnology Index (NBI), and the SPDR S&P Biotech
...
The Wall Street Journal reported a potential mega-merger deal between
Biogen, Inc. (NASDAQ:BIIB) and Merck & Co. (NYSE:MRK) or Allergan PLC
(NYSE:AGN) in early
...
Shares of Pfizer (NYSE:PFE) have declined about 10% since August 1 along with the S&P 500 Healthcare sector down 6.5%. In late August, the company announced the
...
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), and shares of Mylan N.V. (NASDAQ:MYL) tumbled 3.36%
...
The iShares Nasdaq Biotechnology ETF
(NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), has been range-bound between $240 and $290 since January, on concerns about the supposed political dark cloud
...
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), has been range-bound between $240 and $290 since January, on concerns about the supposed political dark cloud
...
Shares of Eli Lilly and Company
(NYSE:LLY) have surged 11.06% from its March low, along with the S&P 500 Healthcare sector, up about 4.85% despite mixed
first ...
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), has pulled back sharply since the beginning of June, on concerns about the Fed interest rate hike, the Brexit vote
...
Shares of Bristol-Myers Squibb Co.
(NYSE:BMY) have surged 25.71% from the February low, along with the S&P 500 Healthcare sector, up about 14.35% despite the political
...
The Healthcare Select Sector SPDR ETF (NYSEARCA:XLV), which tracks S&P 500 Healthcare, has been range-bound between $63.50 and $73.00 per share since
mid-2015 ...
Shares of Merck & Co. Inc. (NYSE:MRK) have pulled back about 5.75% from the April high, along with the S&P 500 Healthcare sector, down 2.38%, on concerns about
...
The iShares Nasdaq Biotechnology ETF
(NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), was under selling pressure last week, down 7.07%, after the Senate Special Committee on Aging conducted its
third ...
Shares of Pfizer
(NYSE:PFE) have climbed about 6% higher since April 6, along with the S&P 500 Healthcare sector, up 4.9%, when the company announced the termination of
...
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), has been range-bound since February while the broader
...
The iShares Nasdaq Biotechnology ETF
(NASDAQ:IBB), which tracks the Nasdaq Biotechnology Index (NASDAQ:NBI), has pulled back sharply since the beginning of March,
...
After six months of back and forth negotiations, Shire PLC
(NASDAQ:SHPG) and Baxalta Inc. (NYSE:BXLT) decided in January to make a $32 billion deal that would create the
...
